Literature DB >> 8554520

Early alterations in the brown adipose tissue adenylate cyclase system of pre-obese Zucker rat fa/fa pups: decreased G-proteins and beta 3-adrenoceptor activities.

C Charon1, S Krief, F Diot-Dupuy, A D Strosberg, L J Emorine, R Bazin.   

Abstract

This study was undertaken to determine whether receptor and non-receptor components of the adenylate cyclase (AC) cascade were altered in brown adipose tissue (BAT) of 14-day-old pre-obese (fa/fa) rats, before endocrine status is strongly modified by fa gene expression. Activity of the AC catalytic subunit did not differ between the two genotypes. In fa/fa rats compared with control Fa/fa rats, there was a 50% decrease in the activity of alpha Gs (stimulated by NaF or guanosine 5'-[gamma-thio]triphosphate) but no change in protein content (Western blotting). alpha Gi function, assessed by the inhibitory action of low concentrations of guanosine 5'-[beta gamma-imido]triphosphate upon 10(-4) M forskolin-stimulated AC activity, was equally low in both genotypes. Analysis of dose-response curves for different beta-agonists revealed that (i) both the basal and the maximally stimulated activity of AC were 2-fold lower in fa/fa rats than in Fa/fa rats; (ii) BRL37344 and CGP12177 (beta 3 agonists) were less potent in fa/fa than in Fa/fa rats (Kact. multiplied by 2); (iii) noradrenaline and isoprenaline (Iso), at the low-affinity site (beta 3-AR), were less potent in fa/fa than in Fa/fa pups (Kact. increased by 30 and 20% respectively). At the high-affinity site (mainly beta 1) these two agonists were more potent in fa/fa than in Fa/fa rats (Kact. decreased by 40 and 80% respectively). In good agreement with the latter result, the beta 1-adrenergic receptor (beta 1-AR)-selective antagonist CGP20712A had more effect on the Iso-stimulated AC activity in pre-obese than in lean pups (2-fold decreased in IC50). Binding experiments with [3H]CGP12177 show that in BAT of suckling rats, beta 3-ARs represent 80% of the total beta-ARs. Bmax values for the two sites were not affected by the genotype, although the beta 3-AR mRNA concentration in BAT (quantitative reverse-transcriptase PCR) was 3-fold lower in fa/fa rats than in Fa/fa pups. In conclusion, these results provide evidence for alterations in beta 1- and beta 3-AR signalling in BAT of 14-day-old suckling pre-obese Zucker rats with a decreased activity of alpha Gs. The impaired AC responsiveness to catecholamines might be a primary contributor to the development of this genetic obesity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554520      PMCID: PMC1136182          DOI: 10.1042/bj3120781

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Radioligand binding studies of the atypical beta 3-adrenergic receptor in rat brown adipose tissue using [3H]CGP 12177.

Authors:  P Muzzin; J P Revelli; C M Fraser; J P Giacobino
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

2.  Decreased T4-to-T3 conversion in brown adipose tissue of Zucker fa/fa pups before the onset of obesity.

Authors:  V Marie; F Dupuy; R Bazin
Journal:  Am J Physiol       Date:  1992-07

3.  Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat.

Authors:  A Chaudhry; J G Granneman
Journal:  Am J Physiol       Date:  1991-08

Review 4.  Fat cell adrenergic receptors and the control of white and brown fat cell function.

Authors:  M Lafontan; M Berlan
Journal:  J Lipid Res       Date:  1993-07       Impact factor: 5.922

5.  Differential interaction of beta 1- and beta 3-adrenergic receptors with Gi in rat adipocytes.

Authors:  A Chaudhry; R G MacKenzie; L M Georgic; J G Granneman
Journal:  Cell Signal       Date:  1994-05       Impact factor: 4.315

6.  Transcriptional down-regulation by insulin of the beta 3-adrenergic receptor expression in 3T3-F442A adipocytes: a mechanism for repressing the cAMP signaling pathway.

Authors:  B Fève; K Elhadri; A Quignard-Boulangé; J Pairault
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Alpha-subunits of Gs and Gi in adipocyte plasma membranes of genetically diabetic (db/db) mice.

Authors:  N Bégin-Heick
Journal:  Am J Physiol       Date:  1992-07

8.  Transcriptional modulation by n-butyric acid of beta 1-, beta 2-, and beta 3-adrenergic receptor balance in 3T3-F442A adipocytes.

Authors:  S Krief; B Fève; B Baude; V Zilberfarb; A D Strosberg; J Pairault; L J Emorine
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

9.  Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.

Authors:  S Collins; K W Daniel; E M Rohlfs; V Ramkumar; I L Taylor; T W Gettys
Journal:  Mol Endocrinol       Date:  1994-04

10.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

View more
  4 in total

Review 1.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

2.  Interaction of amiodarone and triiodothyronine on the expression of beta-adrenoceptors in brown adipose tissue of rat.

Authors:  H Adli; R Bazin; G Y Perret
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin.

Authors:  K E Hadri; C Charon; J Pairault; S Hauguel-De Mouzon; A Quignard-Boulangé; B Fève
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

4.  Adult type 3 adenylyl cyclase-deficient mice are obese.

Authors:  Zhenshan Wang; Vicky Li; Guy C K Chan; Trongha Phan; Aaron S Nudelman; Zhengui Xia; Daniel R Storm
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.